Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-06-04 @ 4:28 AM
Study NCT ID:
NCT05444894
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-02
First Post:
2022-06-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)
Sponsor:
Editas Medicine, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EM-301-BThal-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None